US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US6726930B1
(en)
*
|
1993-09-09 |
2004-04-27 |
Penwest Pharmaceuticals Co. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
US5612053A
(en)
*
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
US6540993B1
(en)
|
1995-06-27 |
2003-04-01 |
Wyeth |
Method of treating inflammatory bowel disease using a topical formulation of IL-11
|
WO1997026865A1
(en)
*
|
1996-01-29 |
1997-07-31 |
Edward Mendell Co., Inc. |
Sustained release excipient
|
US5855913A
(en)
*
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
USRE37053E1
(en)
|
1996-05-24 |
2001-02-13 |
Massachusetts Institute Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
US20020052310A1
(en)
*
|
1997-09-15 |
2002-05-02 |
Massachusetts Institute Of Technology The Penn State Research Foundation |
Particles for inhalation having sustained release properties
|
US6503480B1
(en)
|
1997-05-23 |
2003-01-07 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
US5985309A
(en)
*
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
US5874064A
(en)
*
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US5846568A
(en)
*
|
1996-09-19 |
1998-12-08 |
Xyrofin Oy |
Directly compressible lactitol and method
|
US6129905A
(en)
*
|
1997-04-21 |
2000-10-10 |
Aeropharm Technology, Inc. |
Aerosol formulations containing a sugar as a dispersant
|
EP0876814A1
(en)
*
|
1997-05-07 |
1998-11-11 |
"PHARLYSE", Société Anonyme |
Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
|
US7052678B2
(en)
|
1997-09-15 |
2006-05-30 |
Massachusetts Institute Of Technology |
Particles for inhalation having sustained release properties
|
IN186245B
(es)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
US6433040B1
(en)
*
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US20020017295A1
(en)
*
|
2000-07-07 |
2002-02-14 |
Weers Jeffry G. |
Phospholipid-based powders for inhalation
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6946117B1
(en)
*
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
JP3005657B2
(ja)
*
|
1997-11-19 |
2000-01-31 |
彰 堀金 |
凍結乾燥方法、装置および凍結乾燥物
|
US7022683B1
(en)
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
US6956021B1
(en)
*
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
US6458338B1
(en)
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
US6599883B1
(en)
|
1998-10-30 |
2003-07-29 |
Nastech Pharmaceutical Company, Inc. |
Nasal delivery of xylitol
|
AU772891B2
(en)
|
1998-12-11 |
2004-05-13 |
Nostrum Pharmaceuticals, Inc. |
Sustained release tablet containing hydrocolloid and cellulose ether
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US20010036481A1
(en)
*
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
JP2003507410A
(ja)
*
|
1999-08-25 |
2003-02-25 |
アドバンスト インハレーション リサーチ,インコーポレイテッド |
乾燥粉末製剤からの放出調節
|
JP2003509478A
(ja)
*
|
1999-09-21 |
2003-03-11 |
エモリー・ユニバーシティ |
血小板関連障害を処置する方法および組成物
|
JP3893058B2
(ja)
*
|
1999-09-30 |
2007-03-14 |
ペンウェスト ファーマシューティカルズ カンパニー |
高度に可溶性の薬物のための徐放性マトリックス系
|
AU2001230533A1
(en)
*
|
2000-02-04 |
2001-08-14 |
Kissei Pharmaceutical Co. Ltd. |
Powdered preparation for inhalation and powder inhalant containing the same packed
|
GB0008660D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
GB0009468D0
(en)
*
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formulations for use in inhaler devices
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
WO2001085136A2
(en)
*
|
2000-05-10 |
2001-11-15 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
PT1913939T
(pt)
|
2000-06-27 |
2017-07-19 |
Vectura Ltd |
Formulações para utilização em dispositivos inalatórios
|
AU2001280934A1
(en)
*
|
2000-07-28 |
2002-02-13 |
Alliance Pharmaceutical Corp. |
Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
|
CA2423558A1
(en)
*
|
2000-10-03 |
2002-04-11 |
Penwest Pharmaceuticals Company |
Delivery system for multi-pharmaceutical active materials at various release rates
|
EP1920763B2
(en)
|
2000-11-30 |
2022-06-15 |
Vectura Limited |
Pharmaceutical compositions for inhalation
|
PT1337239E
(pt)
*
|
2000-11-30 |
2010-01-26 |
Vectura Ltd |
Partículas servindo à preparação de uma composição farmacêutica
|
US20030125236A1
(en)
*
|
2000-12-29 |
2003-07-03 |
Advenced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
US20020141946A1
(en)
*
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
JP2005504715A
(ja)
|
2000-12-29 |
2005-02-17 |
アドバンスト インハレーション リサーチ,インコーポレイテッド |
持続放出特性を有する吸入用粒子
|
US7494669B2
(en)
*
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
US6777000B2
(en)
*
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
HUP0501071A3
(en)
*
|
2001-03-13 |
2007-06-28 |
Penwest Pharmaceutical Co |
Chronotherapeutic dosage forms
|
GB0107106D0
(en)
*
|
2001-03-21 |
2001-05-09 |
Boehringer Ingelheim Pharma |
Powder inhaler formulations
|
US7498019B2
(en)
|
2001-05-24 |
2009-03-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of headache through an inhalation route
|
ATE415155T1
(de)
*
|
2001-05-24 |
2008-12-15 |
Alexza Pharmaceuticals Inc |
Verabreichung von alprazolam, estazolam, midazolam oder triazolam durch inhalation
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
US6805853B2
(en)
*
|
2001-11-09 |
2004-10-19 |
Alexza Molecular Delivery Corporation |
Delivery of diazepam through an inhalation route
|
WO2002094242A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of rizatriptan or zolmitriptan through an inhalation route
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
AU2002303868B2
(en)
*
|
2001-05-24 |
2008-09-04 |
Alexza Pharmaceuticals, Inc. |
Delivery of antihistamines through an inhalation route
|
WO2002094240A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of physiologically active compounds through an inhalation route
|
US7090830B2
(en)
*
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
WO2002094216A2
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of stimulants through an inhalation route
|
EP1392262A1
(en)
*
|
2001-05-24 |
2004-03-03 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
DE60228231D1
(de)
*
|
2001-05-24 |
2008-09-25 |
Alexza Pharmaceuticals Inc |
Verabreichung von anti-parkinsonmitteln durch inhalation
|
US7766013B2
(en)
*
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
US6482429B1
(en)
*
|
2001-06-20 |
2002-11-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Stable powder inhalation dosage formulation
|
WO2003002258A1
(en)
*
|
2001-06-29 |
2003-01-09 |
Eurand Pharmaceuticals Ltd |
Drug activation process and vibrational mill therefor
|
US20030129234A1
(en)
*
|
2001-07-06 |
2003-07-10 |
Penwest Pharmaceuticals Company |
Methods of making sustained release formulations of oxymorphone
|
US8329216B2
(en)
*
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
BR0205721A
(pt)
*
|
2001-07-06 |
2003-09-30 |
Endo Pharmaceuticals Inc |
Formulações de oximorfona de liberação controlada
|
EP1429730A4
(en)
*
|
2001-09-26 |
2010-06-16 |
Penwest Pharmaceuticals Compan |
OPIOID FORMULATIONS WITH REDUCED ABUSE POTENTIAL
|
JP2005510501A
(ja)
*
|
2001-10-19 |
2005-04-21 |
マキシム ファーマシューティカルス,インコーポレイテッド |
肝臓疾患治療へのヒスタミンの使用
|
US6896894B2
(en)
*
|
2001-10-30 |
2005-05-24 |
Battelle Memorial Institute |
Proteins stabilized with polysaccharide gums
|
WO2003043603A1
(en)
*
|
2001-11-20 |
2003-05-30 |
Advanced Inhalation Research, Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
ES2415654T3
(es)
*
|
2001-11-20 |
2013-07-26 |
Civitas Therapeutics, Inc. |
Composiciones particuladas mejoradas para suministro pulmonar
|
EP1446102A1
(en)
|
2001-11-21 |
2004-08-18 |
Alexza Molecular Delivery Corporation |
Delivery of caffeine through an inhalation route
|
EP1458360B1
(en)
|
2001-12-19 |
2011-05-11 |
Novartis AG |
Pulmonary delivery of aminoglycosides
|
SE0200657D0
(sv)
*
|
2002-03-04 |
2002-03-04 |
Astrazeneca Ab |
Novel Formulation
|
EP1480691A4
(en)
*
|
2002-03-05 |
2007-11-28 |
Univ State Cleveland |
AGGLOMERATED PARTICLES FOR ADMINISTERING AEROSOL DRUGS
|
CA2481091A1
(en)
*
|
2002-04-05 |
2003-10-23 |
Penwest Pharmaceuticals Co. |
Sustained release metoprolol formulations
|
US20050201948A1
(en)
*
|
2002-04-12 |
2005-09-15 |
Ellison Mark Jason H |
Excipient for use in dry powder inhalation preparations
|
US20030204180A1
(en)
*
|
2002-04-30 |
2003-10-30 |
Kimberly-Clark Worldwide, Inc. |
Temperature responsive delivery systems
|
US8003080B2
(en)
|
2002-05-13 |
2011-08-23 |
Alexza Pharmaceuticals, Inc. |
Delivery of drug amines through an inhalation route
|
SI1531794T1
(sl)
*
|
2002-06-28 |
2017-12-29 |
Civitas Therapeteutics, Inc. |
Epinefrin za vdihavanje
|
US20040023935A1
(en)
*
|
2002-08-02 |
2004-02-05 |
Dey, L.P. |
Inhalation compositions, methods of use thereof, and process for preparation of same
|
EP1534302A4
(en)
*
|
2002-08-22 |
2009-01-07 |
Nutrition 21 Inc |
ARGININILICATE / INOSITOL COMPLEX AND ITS USE
|
US20040105818A1
(en)
*
|
2002-11-26 |
2004-06-03 |
Alexza Molecular Delivery Corporation |
Diuretic aerosols and methods of making and using them
|
AU2003295823B2
(en)
*
|
2002-11-26 |
2009-11-05 |
Alexza Pharmaceuticals, Inc. |
Treatment of headache with antipsychotics delivered by inhalation
|
US7550133B2
(en)
*
|
2002-11-26 |
2009-06-23 |
Alexza Pharmaceuticals, Inc. |
Respiratory drug condensation aerosols and methods of making and using them
|
WO2004047844A1
(en)
*
|
2002-11-26 |
2004-06-10 |
Alexza Pharmaceuticals, Inc. |
Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
US20040109826A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Dey, L.P. |
Stabilized albuterol compositions and method of preparation thereof
|
KR20050105490A
(ko)
*
|
2003-02-26 |
2005-11-04 |
오츠카 세이야쿠 가부시키가이샤 |
경폐 투여용 서방성 제제학적 조성물
|
EP1625334B9
(en)
|
2003-05-21 |
2012-07-25 |
Alexza Pharmaceuticals, Inc. |
Percussively ignited self-contained heating unit
|
GB0312148D0
(en)
|
2003-05-28 |
2003-07-02 |
Aventis Pharma Ltd |
Stabilized pharmaceutical products
|
US6994726B2
(en)
*
|
2004-05-25 |
2006-02-07 |
Calcitec, Inc. |
Dual function prosthetic bone implant and method for preparing the same
|
NO319624B1
(no)
|
2003-09-15 |
2005-09-05 |
Trouw Internat Bv |
Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
|
WO2005027843A2
(en)
*
|
2003-09-19 |
2005-03-31 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms
|
EA200600598A1
(ru)
*
|
2003-09-19 |
2006-08-25 |
Пенвест Фармасьютикалз Ко. |
Лекарственные формы замедленного высвобождения
|
US20050171192A1
(en)
*
|
2003-12-11 |
2005-08-04 |
Gehlsen Kurt R. |
Use of histamine to treat bone disease
|
WO2005061088A1
(en)
*
|
2003-12-22 |
2005-07-07 |
Finlay Warren H |
Powder formation by atmospheric spray-freeze drying
|
US8957034B2
(en)
*
|
2004-01-28 |
2015-02-17 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
GB0409703D0
(en)
*
|
2004-04-30 |
2004-06-02 |
Vectura Ltd |
Pharmaceutical compositions
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
US20060002913A1
(en)
*
|
2004-06-22 |
2006-01-05 |
Gehlsen Kurt R |
Use of histamine and related compounds to treat disorders affecting muscle function
|
EP1763344A1
(en)
*
|
2004-06-29 |
2007-03-21 |
Boehringer Ingelheim International GmbH |
Medicaments for inhalation comprising steroids and an anticholinergic
|
US20060004076A1
(en)
*
|
2004-06-30 |
2006-01-05 |
Inflabloc Pharmaceuticals, Inc. |
Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation
|
US20070031342A1
(en)
*
|
2005-06-22 |
2007-02-08 |
Nektar Therapeutics |
Sustained release microparticles for pulmonary delivery
|
JP2009519972A
(ja)
*
|
2005-12-15 |
2009-05-21 |
アキュスフィア, インコーポレイテッド |
粒子ベースの経肺投与または経鼻投与用製薬の製造方法
|
EP1973527B1
(en)
*
|
2005-12-15 |
2009-10-07 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for parenteral administration
|
JP4907191B2
(ja)
*
|
2006-02-17 |
2012-03-28 |
日本発條株式会社 |
導電性接触子ユニット
|
US20070212414A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Penwest Pharmaceuticals Co. |
Ethanol-resistant sustained release formulations
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
US20100215580A1
(en)
*
|
2006-09-08 |
2010-08-26 |
The Johns Hopkins University |
Compositions and methods for enhancing transport through mucus
|
US9032971B2
(en)
|
2006-11-15 |
2015-05-19 |
Philip Morris Usa Inc. |
Moist tobacco product and method of making
|
KR20090094336A
(ko)
|
2006-11-27 |
2009-09-04 |
하. 룬트벡 아크티에 셀스카브 |
헤테로아릴 아미드 유도체
|
WO2008080170A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Alexza Pharmaceuticals, Inc. |
Mixed drug aerosol compositiions
|
ES2594867T3
(es)
|
2007-03-09 |
2016-12-23 |
Alexza Pharmaceuticals, Inc. |
Unidad de calentamiento para usar en un dispositivo de administración de fármaco
|
US20090124650A1
(en)
*
|
2007-06-21 |
2009-05-14 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
|
GB2460915B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
|
BRPI1013872A2
(pt)
*
|
2009-03-26 |
2018-06-19 |
Pulmatrix Inc |
formulações de citrato de cálcio e lactato de cálcio para alteração de propriedades biofísicas do revestimento da mucosa
|
CN102497853B
(zh)
|
2009-03-26 |
2018-03-23 |
普马特里克斯营业公司 |
治疗肺病的干粉配方与方法
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
DK2435024T3
(en)
*
|
2009-05-29 |
2016-10-24 |
Pearl Therapeutics Inc |
Compositions for the respiratory delivery of active agents and related methods and systems
|
KR101834940B1
(ko)
*
|
2010-03-22 |
2018-03-06 |
(주)바이오시네틱스 |
나노입자 제조방법
|
EP2611438B1
(en)
|
2010-08-30 |
2020-04-01 |
Pulmatrix Operating Company, Inc. |
Dry powder formulations and methods for treating pulmonary diseases
|
EP2464346A1
(en)
|
2010-08-30 |
2012-06-20 |
Pulmatrix, Inc. |
Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
|
DK2621488T3
(en)
|
2010-09-29 |
2019-03-04 |
Pulmatrix Operating Co Inc |
CATIONIC DRY POWDER
|
RU2017144619A
(ru)
|
2010-09-29 |
2019-02-20 |
Пулмэтрикс, Инк. |
Катионы одновалентных металлов сухих порошков для ингаляций
|
CN109999013A
(zh)
|
2012-02-29 |
2019-07-12 |
普马特里克斯营业公司 |
可吸入干粉剂
|
US20150038719A1
(en)
*
|
2012-03-14 |
2015-02-05 |
Ltt Bio-Pharma Co., Ltd. |
Agent for Ameliorating Chronic Obstructive Pulmonary Disease
|
CA2871778C
(en)
|
2012-05-03 |
2022-09-13 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
KR102154880B1
(ko)
|
2012-05-03 |
2020-09-10 |
칼라 파마슈티컬스, 인크. |
개선된 점막 수송을 나타내는 제약 나노입자
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US20140275517A1
(en)
|
2013-03-15 |
2014-09-18 |
Pearl Therapeutics, Inc. |
Methods and systems for conditioning of particulate crystalline materials
|
WO2014165303A1
(en)
|
2013-04-01 |
2014-10-09 |
Pulmatrix, Inc. |
Tiotropium dry powders
|
US11191735B2
(en)
|
2015-03-13 |
2021-12-07 |
Nutrition 21, Llc |
Arginine silicate for periodontal disease
|
CA3004886A1
(en)
|
2015-11-12 |
2017-05-18 |
Graybug Vision, Inc. |
Aggregating microparticles for medical therapy
|
US20170135969A1
(en)
|
2015-11-12 |
2017-05-18 |
Jds Therapeutics, Llc |
Topical arginine-silicate-inositol for wound healing
|
GB2600888B
(en)
|
2016-09-01 |
2022-08-10 |
Nutrition 21 Llc |
Magnesium biotinate compositions and methods of use
|
US11160870B2
(en)
|
2017-05-10 |
2021-11-02 |
Graybug Vision, Inc. |
Extended release microparticles and suspensions thereof for medical therapy
|
CN113242738A
(zh)
*
|
2018-10-22 |
2021-08-10 |
Ioi油脂化学品有限责任公司 |
适用于压实为成形体的粉末材料的添加剂
|
CN113329680A
(zh)
|
2018-11-02 |
2021-08-31 |
营养21有限责任公司 |
用于改善视频游戏者认知功能的含有肌醇稳定的精氨酸硅酸盐复合物和肌醇的组合物
|
AU2020407071A1
(en)
|
2019-12-16 |
2022-07-07 |
Nutrition 21, Llc |
Methods of production of arginine-silicate complexes
|